Last reviewed · How we verify
NCT05135026
Ultrasonography and Health Education Can Reduce the Unnecessary Caesarean Section in Bangladesh
NA trial testing Ultrasonograpgy in Reduce Unnecessary Caesarean Section in 288 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | Hiroshima University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 288 |
| Start date | 28 November 2021 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Bangladesh |
Drugs / interventions tested
- Ultrasonograpgy
Conditions studied
- Reduce Unnecessary Caesarean Section — all drugs for Reduce Unnecessary Caesarean Section →
- Increase Institutional Delivery — all drugs for Increase Institutional Delivery →
- Increase Antenatal Care — all drugs for Increase Antenatal Care →
Sponsor
Hiroshima University
Who can join
Eligibility, female only, with Reduce Unnecessary Caesarean Section or Increase Institutional Delivery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A caesarean section (C/S) is a surgical procedure performed to prevent difficulties during childbirth. World Health Organization considered the standard rate for the C/S would be between 10% and 15%. However, since 2000 the rate of C/S was increasing globally, and it became about twofold from 12.1% to 21.1% in 2015. In Bangladesh, C/S continued to increase from 8% (2007) to 33% (2017). Medically unnecessary C/S was estimated about 77% of all C/S in 2018, and it was increased from 66% since 2016. In Bangladesh, unnecessary C/S observed 9.0% and 3.2% C/S done due to avoid labour pain and 5.8% for the convenience of the mother. The economic burden of each C/S is average USD 612 and unfortunately, each patient spends this amount of money from out of pocket. Aim of this study is to do ultrasonography and health education can reduce unnecessary caesarean section among pregnant women compared to control group in a resource poor setting. Investigators will conduct this randomized controlled trial (RCT) at Dhaka and Sir Salimullah Medical College \& Hospital, and two rural Upazila Health Complexes (Savar Upazila Health Complex and Munshigonj General Hospital). Investigators will randomly select one urban hospital from two urban hospitals and one rural hospital from two rural hospitals for the intervention. The other one urban and one rural hospital will be assigned as control hospitals. One research staff, who will not involve any of the research activity of this trial, will do this randomization. Pregnant mothers will be identified and recruited during their routine antenatal visits. Pregnant mothers receive 2 USG during their routine ANC visits at 1st visit of 8-12 weeks and 4th visit of 36-38 weeks. In the intervention centres, Investigators will perform additional 4 ANC visits at 20, 30, 36 and 40 weeks (total 8 visits) and USG additional 2 times during the 2nd visit of 24-26 weeks and 5th visit of 34 weeks (2 routine USG + 2 USG in 3rd and 5th ANC visits and even more USG if needed + Health education; pictorial flip chart showing danger sign during pregnancy and potential risks for unnecessary caesarean delivery to increase awareness for safe delivery) for all the enrolled pregnant mothers. In the control centres, Investigators will collect information from the pregnant mothers. Investigators are expecting the pregnant women who will receive antenatal care with ultrasonography and health education will have reduced number of unnecessary C/S compared to control group who will not receive those.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effectiveness of WHO-recommended antenatal care visits, ultrasonography, and health education in reducing unnecessary caesarean sections among pregnant women in Bangladesh: a hospital-based randomised controlled trial.
Shirin H, K A T M Ehsanul H, Hawlader MDH, Masud SB, et al · · 2025 · cited 1× · PMID 40576427 · DOI 10.7189/jogh.15.04182 -
Association of Ultrasonography and Health Education during Antenatal Visits among Pregnant Women to Reduce Unnecessary Caesarean Section in Bangladesh: Study Protocol for a Cluster Randomized Control Trial.
Shirin H, Moriyama M, Huq KATME, Rahman MM, et al · · 2022 · cited 1× · PMID 36548143 · DOI 10.3390/mps5060101
Verify or expand the search:
- PubMed search for NCT05135026
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hiroshima University trials
Trials by the same sponsor.
- NCT07527429 — Procedure Manual-Based Simulation Training to Improve Operating Room Nurses' Core Competencies · NA · not yet recruiting
- NCT07299799 — Evidence-Based Nursing to Reduce Adverse Events Regarding Ventilator Associated Pneumonia, Pressure Injuries and Central · NA · not yet recruiting
- NCT07384650 — Post-stroke Nurse-led Rehabilitation to Improve Functional Activity and Community Participation in Bangladesh · NA · recruiting
- NCT07310680 — Impact of mHealth Education on Hemoglobin Level Among Pregnant Women With Anemia in Rural Bangladesh. · NA · not yet recruiting
- NCT06871553 — The Self-management Program on Hemodialysis Patients in Cambodia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05135026 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hiroshima University
- Last refreshed: 23 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05135026.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing